Document Detail


Assessment of myoelectrical signal parameters in estrogen, progesterone, and human chorionic gonadotropin administered in nonpregnant rat myometrium after ovariectomy.
MedLine Citation:
PMID:  17509589     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the correlation of myoelectrical signals with spontaneous contractile events and physiological states in the nonisolated uterine horn of rats. DESIGN: In vivo uterine myoelectrical activity recording study. SETTING: Animal and pharmacology laboratory at Inonu University. ANIMAL(S): Thirty-six female Wistar albino rats. INTERVENTION(S): Six animals were not castrated and served as a sham-operated control group; the other 30 were ovariectomized (OVX) and put into groups: unbiased OVX subjects, estrogen (E)-biased OVX subjects, P-biased OVX subjects, E-plus-P-biased OVX subjects, and hCG-biased OVX subjects. An MP100 A-CE was used for data acquisition, and a personal computer was used for processing. MAIN OUTCOME MEASURE(S): Besides the temporal, spectral, and joint time-frequency (spectrotemporal) analysis, some quantitative measures such as standard deviation and mark to space power ratios of myoelectrical signals were measured. RESULT(S): Progesterone, E, and hCG administration down-regulated the power and contraction frequency of the uterine electrical signal. The spectral concentrations that occurred around the 0.9, 0.35, and 0.7 Hz frequency ranges may be distinguishing characteristics for P, E, and hCG, respectively. CONCLUSION(S): Based on the obtained results, uterine contractions change with ovariectomy and administration of hormones. Progesterone, E, and hCG particularly prolong the quiescent periods of the uterus by reducing the frequency of uterine contractions as well as the power of the myoelectrical activity. Individual or combined use of P, E, or hCG might favor quiescence of the uterine muscle and the maintenance of pregnancy.
Authors:
Onder Celik; Seyma Hascalik; M Emin Tagluk; Koray Elter; Hakan Parlakpinar; Ahmet Acet
Related Documents :
18098339 - Prediction of birth weight by fetal crown-rump length and maternal serum levels of preg...
1834489 - Treatment of tubal pregnancy by local injection of prostaglandin: selection of patients...
9363249 - A novel perspective on the role of human chorionic gonadotropin during pregnancy and in...
17728299 - The arabidopsis 3-ketoacyl-coa thiolase-2 (kat2-1) mutant exhibits increased flowering ...
2660539 - Transvaginal sonography in the evaluation of normal early pregnancy: correlation with h...
8446569 - Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal...
6748139 - A reevaluation of placental grading and its clinical significance.
10460699 - Effect of hamster pregnancy on female protein, a homolog of serum amyloid p component.
21414129 - Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a sys...
Publication Detail:
Type:  Journal Article     Date:  2007-05-16
Journal Detail:
Title:  Fertility and sterility     Volume:  89     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-14     Completed Date:  2008-01-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  188-98     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Inonu University Medical Faculty, Malatya, Turkey. oncelik@inonu.edu.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Chorionic Gonadotropin / administration & dosage*
Electromyography
Estrogens, Conjugated (USP) / administration & dosage*
Female
Fertility Agents, Female / administration & dosage*
Humans
Membrane Potentials / drug effects
Myometrium / drug effects*
Ovariectomy*
Progesterone / administration & dosage*
Rats
Rats, Wistar
Signal Processing, Computer-Assisted
Time Factors
Uterine Contraction / drug effects*
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/Estrogens, Conjugated (USP); 0/Fertility Agents, Female; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite.
Next Document:  Development of a rapid, sensitive, and reproducible laboratory test kit for the assessment of plasma...